SCHEMBL25195003

SCHEMBL25195003

Fc1ccc(Cl)cc1-c1cc2c3ccccc3sc2c2c1[nH]c1ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 5/20 0.46
▸ CCND1 P24385 5/20 0.46
▸ MAP3K9 P80192 3/20 0.46
▸ MAP3K11 Q16584 3/20 0.46
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ MAPT P10636 2/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ TNKS O95271 2/20 0.44
▸ TNKS2 Q9H2K2 2/20 0.44
▸ CCNE2 O96020 3/20 0.43
▸ CCNE1 P24864 3/20 0.43
▸ CDK2 P24941 3/20 0.43
▸ CAMK2B Q13554 3/20 0.43
▸ CAMK2G Q13555 3/20 0.43
▸ CAMK2D Q13557 3/20 0.43
▸ CAMK2A Q9UQM7 3/20 0.43
▸ NTRK1 P04629 1/20 0.40
▸ MAP3K10 Q02779 1/20 0.40
▸ GABRP O00591 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30388681 1.00 CDK4 (0.46) CDK4CCND1MAP3K9MAP3K11MEN1
SCHEMBL30388329 0.80 MAP3K9 (0.40) CDK4CCND1MAP3K9MAP3K11MEN1
SCHEMBL25190261 0.80 MAP3K9 (0.40) CDK4CCND1MAP3K9MAP3K11MEN1
SCHEMBL21282039 0.76 MEN1 (0.59) CDK4CCND1MAP3K9MAP3K11MEN1
SCHEMBL15638451 0.76 KMT2A (0.49) CDK4CCND1MAP3K9MAP3K11MEN1
SCHEMBL30388393 0.74 CCNE2 (0.43) CDK4CCND1MAP3K9MAP3K11MEN1
SCHEMBL25202208 0.74 CCNE2 (0.43) CDK4CCND1MAP3K9MAP3K11MEN1
SCHEMBL25201976 0.73 MEN1 (0.55) CDK4CCND1MAP3K9MAP3K11MEN1
SCHEMBL25996710 0.71 MEN1 (0.56) CDK4CCND1MAP3K9MAP3K11MEN1
SCHEMBL15138822 0.70 MEN1 (0.62) CDK4CCND1MAP3K9MAP3K11MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159550-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-25 — — US disclosed
US-20230159550-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-25 — — US disclosed
US-20230159550-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159550-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, ODC1 CDK4 1358/4885CCND1 127/4885MAP3K9 3120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback